Furthermore, BMP2, NCF1, HSPB1, PIGT, PTX3, CCNA2, and CCNB2 exhibited increased expression, while DES displayed decreased expression in glioma tissues (Fig. 1D). This evidence concerns the gene NCF1 and central nervous system cancer.